Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736
Andrew S. Moore(Children's Health Queensland Hospital and Health Service), Spiros Linardopoulos(Abzena (United Kingdom))
Cited by 26
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|369
Aurora-A Regulation of Nuclear Factor-κB Signaling by Phosphorylation of IκBα
|Cancer Research|2007|109